PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

Nature Medicine

Volumn 9, Issue 3, 2003, Pages 352-355

  Tunaru, Sorin ^a   Kero, Jukka ^a   Schaub, Annette ^b   Wufka, Christian ^b,c   Blaukat, Andree ^a   Pfeffer, Klaus ^b,c   Offermanns, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; BETA 2 ADRENERGIC RECEPTOR; COMPLEMENTARY DNA; CYCLIC AMP; CYTOKINE; FATTY ACID; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; GENOMIC DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; HM74 RECEPTOR; ISOPRENALINE; LIPID; NICOTINIC ACID; NICOTINIC ACID RECEPTOR; ORPHAN RECEPTOR PUMA G; PROTEIN PUMA G; PYRAZINOIC ACID; RNA; TRIACYLGLYCEROL; TRITIUM; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL MODEL; ARTICLE; BINDING SITE; CALCIUM MOBILIZATION; CONTROLLED STUDY; DYSLIPIDEMIA; HYPERLIPIDEMIA; LIGAND BINDING; LIPOLYSIS; MOLECULAR CLONING; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; ANIMALS; ANTILIPEMIC AGENTS; CELL LINE; CLONING, MOLECULAR; FATTY ACIDS, NONESTERIFIED; GENES, REPORTER; GTP-BINDING PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NIACIN; RADIOLIGAND ASSAY; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC; TISSUE DISTRIBUTION; TRIGLYCERIDES;

ANIMALIA; TRITIUM;

EID: 0037352280     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm824     Document Type: Article

References (25)

1. Knopp, R.H. Drug treatment of lipid disorders N. Engl. J. Med. 341, 498-511 (1999).
2. Szapary, P.O. & Rader, D.J. Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol. Curr. Opin. Pharmacol. 1, 113-120 (2001).
3. Hotz, W. Nicotinic acid and its derivatives: a short survey. Adv. Lipid. Res. 20, 195-217 (1983).
4. Olsson, A.G. Nicotinic acid and derivatives. In Handbook of Experimental Pharmacology vol. 109 (eds. Schettler, G. & Habenicht, A.J.R.) 349-400 (Springer-Verlag, Heidelberg, 1994).
5. Carlson, L.A. Studies on the effect of nicotinic acid on catecholamine-stimulated lipolysis in adipose tissue in vitro. Acta Med. Scand. 173, 719 (1963).
6. Butcher, R.W., Baird, C.E. & Sutherland, E.W. Effects of lipolytic and antilipolytic substances on adenosine 3′,5′-monophosphate levels in isolated fat cells. J. Biol. Chem. 243, 17005-17012 (1968).
7. Aktories, K., Schultz, G. & Jakobs, K.H. Regulation of adenylate cyclase activity in hamster adipocytes. Inhibition by prostaglandins, α-adrenergic agonists and nicotinic acid. Naunyn Schmiedebergs Arch. Pharmacol. 312, 167-173 (1980a).
8. Fredholm, B.B. Adenosine and lipolysis. Int. J. Obes. 5, 643-649 (1981).
9. Aktories, K., Schultz, G. & Jakobs K.H. Inactivation of the guanine nucleotide regulatory site mediating inhibition of the adenylate cyclase in hamster adipocytes. Naunyn Schmiedebergs Arch Pharmacol. 321, 247-252 (1982).
10. Aktories, K., Jakobs, K.H. & Schultz, G. Nicotinic acid inhibits adipocyte adenylate cyclase in a hormone-like manner. FEBS Lett. 115, 11-14 (1980b).
11. Lorenzen, A. et al. Characterization of a G protein-coupled receptor for nicotinic acid. Mol. Pharmacol. 59, 349-357 (2001).
12. Nomura, H., Nielsen, B.W. & Matsushima, K. Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. Int. Immunol. 5, 1239-1249 (1993).
13. Schaub, A., Futterer, A. & Pfeffer, K. PUMA-G, an IFN-γ-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. Eur. J. Immunol. 31, 3714-3725 (2001).
14. Lorenzen, A., Stannek, C., Burmeister, A., Kalvinsh, I. & Schwabe, U. G protein-coupled receptor for nicotinic acid in mouse macrophages. Biochem. Pharmacol. 64, 645-648 (2002).
15. Yousefi, S., Cooper, P.R., Mueck, B., Potter, S.L. & Jarai, G. cDNA representational difference analysis of human neutrophils stimulated by GM-CSF. Biochem. Biophys. Res. Commun. 277, 401-409 (2000).
16. 16 couple a wide variety of receptors to phospholipase C. J. Biol. Chem. 270, 15175-15180 (1995).
17. 2+ reporters at the single-cell level. Proc. Natl. Acad. Sci. USA 97, 7260-7265 (2000).
18. Aktories, K., Schultz, G. & Jakobs, K.H. Inhibition of adenylate cyclase and stimulation of a high affinity GTPase by the antilipolytic agents, nicotinic acid, acipimox and various related compounds. Arzneimittelforschung 33, 1525-1527 (1983).
19. -/- mice. Proc. Natl. Acad. Sci. USA 93, 3209-3214 (1996).
20. Kather, H., Aktories, K., Schulz, G. & Jakobs, K.H. Islet-activating protein discriminates the antilipolytic mechanism of insulin from that of other antilipolytic compounds. FESS Lett. 161, 149-152 (1983).
21. Svedmyr, N., Harthon, L. & Lundholm, L. The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man. Clin. Pharmacol. Ther. 10, 559-570 (1969).
22. Carlson, L.A., Oro, L. & Ostman, J. Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia. Acta Med. Scand. 183, 457-465 (1968).
23. Geigy Scientific Tables vol. 3 (ed. Lentner, C.) 129 (Ciba-Geigy, Basle, Switzerland, 1984).
24. J/o. J. Biol. Chem. 277, 31459-31465 (2002).
25. Rodbell, M. Metabolism of isolated fat cells. J. Biol. Chem. 239, 375-380 (1964).